Skip to content

Acupuncture for Reduction of Inflammation

Acupuncture for Reduction of Inflammation in Thyroid and Parathyroid Surgery: Randomized, Prospective Double Blind Pilot Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01937520
Enrollment
20
Registered
2013-09-09
Start date
2013-07-31
Completion date
2015-04-30
Last updated
2017-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid or Parathyroid Surgery

Keywords

acupuncture, inflammation, thyroid, parathyroid

Brief summary

This study is being done because the investigators wish to study ways to improve recovery after surgery. Injury, including surgical injury, causes inflammation. Inflammation is the body's attempt to protect itself and to start the healing process. Some surgical complications are related to the body's natural inflammatory response. Although mainly a healing response, inflammation can also have side effects which delay recovery. The investigators wish to determine the effect of acupuncture on post-operative surgical pain. An increase in pain after surgery can cause distress for patients. Acupuncture is an alternative medicine methodology originating in China that treats patients by manipulating thin, solid needles that have been inserted into acupuncture points in the skin. Acupuncture has been used for the reduction of pain. The investigators would like to see if acupuncture during surgery can provide a lower level of pain, reduced pain medication requirement, and a lower incidence of nausea and vomiting.

Detailed description

Acupuncture has traditionally been used in Asia and is increasingly popular in Western countries to treat a variety of conditions (1). In recent years, acupuncture is widely used to assist in improving pain and inflammatory diseases (2). However, the mechanisms associated with these treatments that influence the immune system are not yet understood. Cytokines like interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) are proposed to be proximal mediators in the early stages of inflammation. They modulate many of the early inflammatory response that is induced by tissue injury, infection, or an immune stimulus (3, 4). Although the response is a critical first line of defense against pathogens, when the inflammatory reaction is uncontrolled, it can cause more damage to the host than the initial stimulus. TNF-α is a pro-inflammatory cytokine that is very effective in local and systemic inflammations (5). In addition, TNF-α increases the production of other inflammatory cytokines such as IL-1β, IL-6, and interleukin-18 (IL-18) during the inflammatory process. Therefore, it initially brings infections under control, produces coagulation in the damaged tissue, and stimulates tissue improvement. An excessive increase of TNF-α level causes an extreme immune reaction and contributes to the development of atherosclerosis, shock, endotoxemia, and chronic inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and inflammatory bowel disease (5-7). Yim and colleagues reported a decrease in increased serum TNF-α, IL-6, and interferon gamma levels by arthritis as a result of electroacupuncture treatment (9). In a rat model for ulcerative colitis, acupuncture inhibited the expression of IL-1β and IL-6 (10). It has been reported that acupuncture significantly reduces complete Freund's adjuvant-induced hind paw edema and mouse air pouch inflammation (11, 12). Acupuncture could also improve immune dysfunction after surgical stress both in human and animals (13, 14). Some cytokines are pro-inflammatory, but others are anti-inflammatory (3). The anti-inflammatory interleukins comprise interleukine-4 (IL-4) and interleukine-10 (IL-10) and these are considered as mediating the down-regulation of immune-inflammatory conditions. Acupuncture for treatment of the ulcerative colitis rats is possibly related with the decrease of IL-1β, a pro-inflammatory cytokine, and the increase of IL-4, an anti-inflammatory cytokine (15). Therefore, it is reasonable to expect that the protective action of acupuncture is exerted by the modulation of pro- and anti-inflammatory cytokines. The restoration of balance between pro- and anti-inflammatory cytokines by acupuncture gives into the mechanisms underlying the immune-modulation effect of acupuncture. Inflammation is associated with pain hypersensitivity that is produced by the release of inflammatory mediators. The pro-inflammatory cytokines play an essential role in pain sensitization (16). The peripheral effects of these cytokines on sensitizing nociceptors have been well documented (16). Post-operative surgical pain can cause significant physiologic and psychologic distress for patients. An increase in pain duration and intensity after surgery can contribute to a variety of complications, including delayed ambulation, pulmonary and thromboembolic complications, increased length of hospital stay, and generalized distress and anxiety. Effective post-surgical pain relief requires a multidisciplinary effort and influences patients' satisfaction with care and successful outcomes (17). Acupuncture has been used for a long time for the reduction of pain. In light of these factors, the use of acupuncture that may allow a reduction in the dosage of conventional analgesics is highly valuable because it can lower the incidence of possible adverse effects. Several trials have demonstrated that patients receiving acupuncture prior to surgery have a lower level of pain, reduced opioid requirement, a lower incidence of post-operative nausea and vomiting, and lower sympatho-adrenal responses (18). The local release of β-endorphin could be responsible for the analgesic effect. β-endorphin may be interacting with cytokines to reduce pain and acupuncture may amplify the interaction between β-endorphin and cytokines. The investigators will ask patients undergoing thyroid and parathyroid surgery to determine how acupuncture restores a balance of pro- and anti-inflammatory cytokines to reduce pain and inflammation before, during, and after surgery. The effect of acupuncture on post-surgical pain will be evaluated. Protocol A prospective randomized, double-blinded (patient and data collector), study of 30 patients undergoing thyroid or parathyroid surgery under general anesthesia, will be conducted to compare the effects of acupuncture on the levels of circulating cytokines between acupuncture group and control group. The control group is to receive the same anesthetic and surgical techniques without the acupuncture. The principal investigator will use the Large intestine 4 (LI-4), the Large intestine 11 (LI-11), and the Stomach 36 (ST-36) acupuncture points (acupoints). LI-4 and LI-11 acupoints lie on the Large intestine meridian (pathway). The Large intestine meridian runs through the frontal neck region including the thyroid. LI-4 point is located in the middle of the 2nd metacarpal bone on the radial side and LI-11 point is located at the lateral end of the transverse cubital crease. Acupuncture on these two acupoints showed increased immune-modulatory effects including cytotoxicity of leukocytes (19, 20). ST-36 point is located on the outside of the anterior crest of the tibia and just below the knee. This point is the most commonly used to reduce general body pain (21). The acupuncture procedures will be performed by an anesthesiologist licensed to do so. After cleaning the skin with alcohol swabs, an acupuncture needle (30 Gauge, 0.30X30 millimeter, Mac Spring Handle Needle, Korea) will be swiftly inserted approximately 5-10 mm deep bilaterally at both LI-4 and LI-11 acupoints of each arm and at ST-36 acupoint of each leg. Electroacupuncture (EA) will be delivered by a stimulator (Digital Electronic Acupunctoscope 4-C, Model AWQ-104L™ Hong Kong, Dist by Lhasa Medical, Weymouth, MA) via electrodes from the stimulator at 10 Hz frequency with the electrical current of continuous wave. This setting showed significant anti-hyperalgesic effects in a rat inflammation model (22, 23) and also inhibited the up-regulation of IL-1β and its messenger Ribonucleic acid (mRNA) compared to the sham control in a rat model of bone cancer pain (24). EA is a particularly therapeutic method in which a small electrical charge is applied to acupuncture needles inserted at the acupoints. EA has the advantage of combining the stimulation of both needles and electricity compared to manual acupuncture alone, and may potentiate the effect of the acupuncture treatment along the meridians. One end of electrode will be attached to the acupuncture needle handle at LI-4 acupoint, and another end will be attached to the acupuncture needle handle at LI-11acupoint bilaterally. For EA on ST-36, one end of electrode will be attached at the right side ST-36 acupoint and another end will be attached at the left side ST-36 acupoint. A symmetrical biphasic wave will be delivered to the electrodes so that the electrode will be alternately positive and negative and the bilateral LI-4, LI-11, and ST-36 acupoints will be stimulated alternately. Mild muscle twitching will be observed. The investigator will stimulate the acupoints as follows: 1. EA will be performed for 30 min (a time that is similar to that used in clinical practice). 2. EA will stop after 30 min of the treatment, but leave the needles on the acupoints. 3. Subsequently, EA will be re-initiated for an additional 30 min. This advanced EA technique showed more increased nitric oxide production in the second interval of EA than that of the first interval, and reduced blood pressure at the end of the second interval in our preliminarily study (25). In addition, this technique increased transient receptor potential vanilloid type-1 receptor immunoreactivity in the acupoints compared to that of non-acupoints (26). The advanced EA treatment will be started just before the beginning of surgery. At the conclusion of the surgical procedure, the acupuncture needles will be removed. The subjects will be awakened and after meeting the criteria for extubation will be transferred to the Post Anesthesia Care Unit (PACU). Blood Samples A second intravenous line will be placed in the other arm after the induction of anesthesia and prior to surgical incision to collect blood samples. 15 ml of blood will be collected at three time points: (1) preinduction, (2) just after the advanced EA treatment (3) after arrival in PACU and prior to additional medication administration (approximately 120 minutes post preinduction sample). These specimens will be placed into vacutainer tubes with no anti-coagulant. Blood will be drawn with a syringe attached directly to the angiocatheter which has been placed intravenously. To prevent hemolysis, blood will be transferred without a needle, to a vacutainer whose top has been removed. The vacutainer top will be replaced and specimens labeled with study name, subject's study ID number, sample number, and dated. Bloods from the first two time points will be kept refrigerated until the final sample is obtained postoperatively. Blood samples will be transported to the Institute for Complementary and Alternative Medicine/School of Health Related Professions Interprofessional Health Research Laboratory within the Department of Clinical Lab Sciences (G level, Bergen Building, 65 Bergen St., Newark). They will be centrifuged, serum removed, aliquoted, and stored at -80C until analysis. Laboratory Analysis Samples will be analyzed for levels of cortisol, C-reactive proteins, and cytokines interleukin (IL)-1α, IL-1β, IL-1ra, IL-2, IL-6, IL-8, IL-10, and TNF-α, by appropriate methods, including ELISA or multiplex fluorescent bead technology. All samples will be run in duplicate on with plates and reagents of the same lot. In addition we will test Adrenocorticotropic hormone (ACTH), glucose and insulin to evaluate the response of the stress. Any samples varying greater than 15% between duplicates will be repeated.

Interventions

DEVICEacupuncture

One half of subjects will receive a standardized acupuncture regiment

placebo

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Not currently pregnant or beast feeding 2. American Society of Anesthesiologists physical status of 1, 2, 3 as determined by your anesthesiologist 3. Patients have a working telephone

Exclusion criteria

1. Uncontrolled high blood pressure (systolic \> 180 mm Hg (millimeters of mercury), diastolic\>110 mm Hg 2. Heart block \>than first degree 3. Pacemaker 4. Cardiac muscle is at risk for injury 5. not English speaking 6. Acupuncture within the last 30 days 7. If you have taken ibuprofen, advil aleve, motrin or aspirin with 5 days of the scheduled surgery. 8. Prior history of drug or alcohol dependence 9. If you are unable to feed, dress or bathe yourself 10. If your breathing tube is not removed prior to leaving the operating room.

Design outcomes

Primary

MeasureTime frameDescription
Reduced Pain Medication Requirementamount of pain medication provided in PACUanalgesia provided in Post Anesthesia Care Unit PACU)
Visual Acuity Score (VAS)arrival in PACU to 2 hours post operativelyVAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average
Morphine EquivalentPACU, day 1 , day 2, day 3equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.
Pain LevelsPACU, day 1 , day 2, day 3Visual Acuity scale 0=no pain 10= worst pain possible

Secondary

MeasureTime frameDescription
Cortisolprior to surgical incision, 1 hour following incision, after arrival in PACUAll blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.
Glucoseserum glucose from baseline to PACU arrivalthe first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.
Tumor Necrosis Factor (TNF)preoperatively-intraoperatively-postoperativelyFirst two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.
iNTERLEUKIN (IL-2 and IL-4)Preoperatively-intraoperatively-postoperativelyboth are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.
(ACTH )Adrenocorticotropic Hormoneserum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACUAll blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only
IL-10Preoperatively-intraoperatively-postoperativelyIL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.
TGFB1Preoperatively-intraoperatively-postoperativelyTGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.
Serum Insulin Levelpreoperative and postoperativeto determine if electroacupuncture reduced hyperglycemia
IL-6Preoperatively-intraoperatively-postoperativelyFirst two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma
Morphine EquivalentPACU to 2 hours post opAll analgesic treatments were converted to morphine equivalents in milligrams .
Morphine Equivalent (mg)PACU arrival to 2 hours post opmorphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture
Modified Quality of Recovery ScaleDay 1, 2, 3Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score

Countries

United States

Participant flow

Recruitment details

Participants were recruited in a Same Day Surgery Suite at a academic medical center. The first participant was enrolled on 7/2/13 and last patient enrolled on 7/15/14.

Participants by arm

ArmCount
Acupuncture
acupuncture will be administered after induction for a period of 30 minutes, followed by a 30 minute rest period and then resumption of acupuncture for 30 minutes. acupuncture: One half of subjects will receive a standardized acupuncture regiment
11
Sham/Placebo
no acupuncture will be done on this group of subjects. Since they are under general anesthesia they will not realize they are acting as control group no acupuncture: placebo
9
Total20

Baseline characteristics

CharacteristicAcupunctureSham/PlaceboTotal
Age, Customized
<45 years
6 participants2 participants8 participants
Age, Customized
45 years or older
5 participants7 participants12 participants
Region of Enrollment
United States
11 participants9 participants20 participants
Sex: Female, Male
Female
9 Participants9 Participants18 Participants
Sex: Female, Male
Male
2 Participants0 Participants2 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 110 / 9
serious
Total, serious adverse events
0 / 110 / 9

Outcome results

Primary

Morphine Equivalent

equivalent doses of morphine for analgesic relief. All analgesic treatments were converted to morphine equivalents in milligrams.

Time frame: PACU, day 1 , day 2, day 3

Population: since gender impacts the threshold for analgesic and pain the effects of electroacupuncture on females was analyzed. The same number of females were in both groups but since one subject had preexisting levels of TNF\>1ug/ml prior to surgery she was eliminated from the dta base

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureMorphine EquivalentPACU3.19 mg morphineStandard Error 1.59
AcupunctureMorphine EquivalentDay 16.31 mg morphineStandard Error 2.14
AcupunctureMorphine EquivalentDay 29.84 mg morphineStandard Error 3.44
AcupunctureMorphine EquivalentDay 37.93 mg morphineStandard Error 3.35
Sham/PlaceboMorphine EquivalentDay 35.25 mg morphineStandard Error 2.32
Sham/PlaceboMorphine EquivalentPACU7.36 mg morphineStandard Error 1.49
Sham/PlaceboMorphine EquivalentDay 27.42 mg morphineStandard Error 2.37
Sham/PlaceboMorphine EquivalentDay 19 mg morphineStandard Error 2.44
Primary

Pain Levels

Visual Acuity scale 0=no pain 10= worst pain possible

Time frame: PACU, day 1 , day 2, day 3

Population: female patients self reported pain experience following surgery

ArmMeasureGroupValue (MEAN)Dispersion
AcupuncturePain LevelsPACU4.88 units on a scaleStandard Error 1.29
AcupuncturePain LevelsDay 16.67 units on a scaleStandard Error 1.09
AcupuncturePain Levelsday25 units on a scaleStandard Error 1.09
AcupuncturePain Levelsday34.28 units on a scaleStandard Error 0.95
Sham/PlaceboPain Levelsday33.33 units on a scaleStandard Error 0.96
Sham/PlaceboPain LevelsPACU6.67 units on a scaleStandard Error 1.01
Sham/PlaceboPain Levelsday25.93 units on a scaleStandard Error 0.49
Sham/PlaceboPain LevelsDay 15.56 units on a scaleStandard Error 0.96
Primary

Reduced Pain Medication Requirement

analgesia provided in Post Anesthesia Care Unit PACU)

Time frame: amount of pain medication provided in PACU

Population: All subjects enrolled in study

ArmMeasureValue (MEAN)Dispersion
AcupunctureReduced Pain Medication Requirement5.43 mg of MorphineStandard Error 1.7
Sham/PlaceboReduced Pain Medication Requirement7.36 mg of MorphineStandard Error 1.49
Primary

Visual Acuity Score (VAS)

VAS is a self reported pain scale with a score ranging from 0 to 10. 0= no pain, 10=worst pain possible. Multiple pain sacores were recorded. single value is reported by average

Time frame: arrival in PACU to 2 hours post operatively

Population: all study participants

ArmMeasureValue (MEAN)Dispersion
AcupunctureVisual Acuity Score (VAS)5.36 units on a scaleStandard Error 0.97
Sham/PlaceboVisual Acuity Score (VAS)6.67 units on a scaleStandard Error 1.01
Secondary

(ACTH )Adrenocorticotropic Hormone

All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia. The data below represents female patients only

Time frame: serum ACTH from baseline/preoperatively,intraoperatively, upon arrival in PACU

Population: females

ArmMeasureGroupValue (MEAN)Dispersion
Acupuncture(ACTH )Adrenocorticotropic Hormonepostoperative53.36 pg/mlStandard Error 33.84
Acupuncture(ACTH )Adrenocorticotropic Hormonepostop>45 years19.4 pg/mlStandard Error 8.09
Acupuncture(ACTH )Adrenocorticotropic Hormoneintraoperative15.26 pg/mlStandard Error 12.13
Acupuncture(ACTH )Adrenocorticotropic Hormonepostop<75kg15.03 pg/mlStandard Error 5.85
Acupuncture(ACTH )Adrenocorticotropic Hormonepost op<45years110 pg/mlStandard Error 88.94
Acupuncture(ACTH )Adrenocorticotropic Hormonepostop>75 kg83.48 pg/mlStandard Error 68.23
Acupuncture(ACTH )Adrenocorticotropic Hormonepreoperative8.56 pg/mlStandard Error 2.6
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepostop>75 kg376.2 pg/mlStandard Error 73.39
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepreoperative21.32 pg/mlStandard Error 7.08
Sham/Placebo(ACTH )Adrenocorticotropic Hormoneintraoperative21.41 pg/mlStandard Error 8.3
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepostoperative202 pg/mlStandard Error 74.37
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepost op<45years276.1 pg/mlStandard Error 221.9
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepostop>45 years177.3 pg/mlStandard Error 80.96
Sham/Placebo(ACTH )Adrenocorticotropic Hormonepostop<75kg27.85 pg/mlStandard Error 14.35
Secondary

Cortisol

All blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.

Time frame: prior to surgical incision, 1 hour following incision, after arrival in PACU

Population: females

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureCortisolintraoperative103.1 ng/mlStandard Error 19.93
AcupunctureCortisolpostoperative>45 years202.4 ng/mlStandard Error 61.55
AcupunctureCortisolpreoperative173.6 ng/mlStandard Error 83.3
AcupunctureCortisolpostoperative<75 kg252.1 ng/mlStandard Error 88.76
AcupunctureCortisolpostoperative<45 years375.6 ng/mlStandard Error 229.1
AcupunctureCortisolpostoperative>75 kg296 ng/mlStandard Error 180.5
AcupunctureCortisolpostoperative267.4 ng/mlStandard Error 89.33
Sham/PlaceboCortisolpostoperative>75 kg618.1 ng/mlStandard Error 114.6
Sham/PlaceboCortisolpostoperative394.4 ng/mlStandard Error 104.6
Sham/PlaceboCortisolpreoperative155.2 ng/mlStandard Error 40.37
Sham/PlaceboCortisolintraoperative145.2 ng/mlStandard Error 26.85
Sham/PlaceboCortisolpostoperative<45 years480 ng/mlStandard Error 302.1
Sham/PlaceboCortisolpostoperative>45 years365.8 ng/mlStandard Error 116.9
Sham/PlaceboCortisolpostoperative<75 kg170.7 ng/mlStandard Error 67.28
Secondary

Glucose

the first two blood samples were collected during general anesthesia, the first prior to surgical incision and electroacupuncture, the second 60 minutes after incision time and at the completion of electroacupuncture, the third after arrival in PACU but before the administration of analgesia.

Time frame: serum glucose from baseline to PACU arrival

Population: females

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureGlucosepostop <75 kg144.3 mg/dLStandard Error 7.22
AcupunctureGlucosepreoperative150.4 mg/dLStandard Error 11.36
AcupunctureGlucoseintraoperative154.3 mg/dLStandard Error 8.75
AcupunctureGlucosepostoperative152.8 mg/dLStandard Error 7.76
AcupunctureGlucosepost op < 45 years154.7 mg/dLStandard Error 9.39
AcupunctureGlucosepost op > 45 years151.6 mg/dLStandard Error 11.88
AcupunctureGlucosepost op >75 kg148.5 mg/dLStandard Error 9.06
Sham/PlaceboGlucosepostop <75 kg210.3 mg/dLStandard Error 32.46
Sham/PlaceboGlucosepost op < 45 years190 mg/dLStandard Error 26
Sham/PlaceboGlucosepreoperative164.4 mg/dLStandard Error 10.94
Sham/PlaceboGlucosepost op >75 kg206.4 mg/dLStandard Error 2.98
Sham/PlaceboGlucoseintraoperative187.1 mg/dLStandard Error 15.82
Sham/PlaceboGlucosepost op > 45 years213.3 mg/dLStandard Error 15.93
Sham/PlaceboGlucosepostoperative208.1 mg/dLStandard Error 13.36
Secondary

IL-10

IL-10 is an anti-inflammatory cytokine marker. First two blood samples were collected during general anesthesia, first prior to surgical incision and EA, 2nd 60 minutes following incision and EA, and the third after arrival in PACU but before administration of analgesia.

Time frame: Preoperatively-intraoperatively-postoperatively

Population: total females; then those grouped by age (\<45years and\>45 years) and weight (\<75 Kg and \>75kg)

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureIL-10IL-10 postoperative16.15 pg/mlStandard Error 9.4
AcupunctureIL-10IL-10>75kg postop32.18 pg/mlStandard Error 26.58
AcupunctureIL-10IL-10 preoperatively5.35 pg/mlStandard Error 0.93
AcupunctureIL-10IL_10 intraoperative7.28 pg/mlStandard Error 1.62
AcupunctureIL-10IL-10 <45 yrs postop40.23 pg/mlStandard Error 13.64
AcupunctureIL-10IL-10 >45 postop7.7 pg/mlStandard Error 1.19
AcupunctureIL-10IL-10 <75kg postop8.6 pg/mlStandard Error 1.6
Sham/PlaceboIL-10IL-10>75kg postop20.47 pg/mlStandard Error 6.1
Sham/PlaceboIL-10IL-10 <45 yrs postop13.64 pg/mlStandard Error 10.07
Sham/PlaceboIL-10IL-10 <75kg postop10.7 pg/mlStandard Error 4.46
Sham/PlaceboIL-10IL-10 preoperatively6.0 pg/mlStandard Error 0.8
Sham/PlaceboIL-10IL-10 >45 postop16.86 pg/mlStandard Error 4.8
Sham/PlaceboIL-10IL_10 intraoperative7.81 pg/mlStandard Error 2.22
Sham/PlaceboIL-10IL-10 postoperative16.14 pg/mlStandard Error 4.07
Secondary

IL-6

First two blood samples were collected during general anesthesia, first prior to Surgical incision and EA, 2nd 60 minutes after incision and EA and the 3rd after arrival in PACU but before administration of analgesia. IL-6 is a critical inflammatory cytokine produced during the acute phase of reaction to trauma

Time frame: Preoperatively-intraoperatively-postoperatively

Population: total female results; then females divided into age groups (\<45 or \>45years) and weights groups (\<75kg and \>75kg)

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureIL-6IL-6 postoperatively26.96 pg/mlStandard Error 10.35
AcupunctureIL-6IL-6 >45 yrs postop29.28 pg/mlStandard Error 16.97
AcupunctureIL-6IL-6 intraoperatively4.98 pg/mlStandard Error 1.1
AcupunctureIL-6IL-6 <75 kg postop37.15 pg/mlStandard Error 28.41
AcupunctureIL-6IL-6 <45 yrs post op23.10 pg/mlStandard Error 5.3
AcupunctureIL-6IL-6 >75 kg postop25.44 pg/mlStandard Error 4.47
AcupunctureIL-6IL-6 preoperatively3.58 pg/mlStandard Error 0.92
Sham/PlaceboIL-6IL-6 >75 kg postop36.61 pg/mlStandard Error 12.95
Sham/PlaceboIL-6IL-6 preoperatively4.65 pg/mlStandard Error 0.34
Sham/PlaceboIL-6IL-6 intraoperatively4.66 pg/mlStandard Error 0.4
Sham/PlaceboIL-6IL-6 postoperatively27.45 pg/mlStandard Error 7.85
Sham/PlaceboIL-6IL-6 <45 yrs post op30.9 pg/mlStandard Error 6.9
Sham/PlaceboIL-6IL-6 >45 yrs postop26.46 pg/mlStandard Error 10.14
Sham/PlaceboIL-6IL-6 <75 kg postop16 pg/mlStandard Error 3.4
Secondary

iNTERLEUKIN (IL-2 and IL-4)

both are IL-2 and IL-4 are critical cytokines regulating the cellular response to induce cellular versus hormone immunity. First two blood samples were collected during general anesthesia: first prior to surgical incision and electroacupuncture, second 60 minutes after incision and electroacupuncture and the 3rd after arrival in PACU but before analgesia.

Time frame: Preoperatively-intraoperatively-postoperatively

Population: all females

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-2preoperative2.64 pg/mlStandard Error 1.53
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-2 postoperative2.33 pg/mlStandard Error 1.31
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-4 postoperative0.41 pg/mlStandard Error 0.12
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-4 preoperative0.52 pg/mlStandard Error 0.15
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-2intraoperative2.38 pg/mlStandard Error 1.3
AcupunctureiNTERLEUKIN (IL-2 and IL-4)IL-4 intraoperative0.57 pg/mlStandard Error 0.27
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-2intraoperative3.4 pg/mlStandard Error 2.87
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-4 postoperative0.37 pg/mlStandard Error 0.1
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-2preoperative4.26 pg/mlStandard Error 3.62
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-4 intraoperative0.56 pg/mlStandard Error 0.28
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-2 postoperative2.77 pg/mlStandard Error 2.24
Sham/PlaceboiNTERLEUKIN (IL-2 and IL-4)IL-4 preoperative0.59 pg/mlStandard Error 0.25
Secondary

Modified Quality of Recovery Scale

Modified patient self reported scale with 9 questions regarding general well being including ability to eat, free from constant pain, able to manage activities of daily living. 0= worst possible score and 18=best outcome score

Time frame: Day 1, 2, 3

Population: all females

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureModified Quality of Recovery ScaleDay 114.5 units on a scaleStandard Error 0.98
AcupunctureModified Quality of Recovery ScaleDay 216 units on a scaleStandard Error 0.73
AcupunctureModified Quality of Recovery ScaleDay 317.57 units on a scaleStandard Error 0.3
Sham/PlaceboModified Quality of Recovery ScaleDay 113.33 units on a scaleStandard Error 0.85
Sham/PlaceboModified Quality of Recovery ScaleDay 215.89 units on a scaleStandard Error 0.75
Sham/PlaceboModified Quality of Recovery ScaleDay 317 units on a scaleStandard Error 0.33
Secondary

Morphine Equivalent

All analgesic treatments were converted to morphine equivalents in milligrams .

Time frame: PACU to 2 hours post op

Population: females grouped by age (\<45 years and 45 years or greater)

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureMorphine Equivalent> 45 years old3.9 mg of MorphineStandard Error 2.52
AcupunctureMorphine Equivalent< 45 years old2 mg of MorphineStandard Error 1.16
Sham/PlaceboMorphine Equivalent> 45 years old6.68 mg of MorphineStandard Error 1.76
Sham/PlaceboMorphine Equivalent< 45 years old9.75 mg of MorphineStandard Error 2.75
Secondary

Morphine Equivalent (mg)

morphine equivalent to analyze whether body weight affected the efficacy of electroacupuncture

Time frame: PACU arrival to 2 hours post op

Population: females with body weight \<75 kg and \>than 75 kg

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureMorphine Equivalent (mg)<75 kg3.25 mg morphineStandard Error 2.38
AcupunctureMorphine Equivalent (mg)>75 kg4.63 mg morphineStandard Error 2.63
Sham/PlaceboMorphine Equivalent (mg)<75 kg9.69 mg morphineStandard Error 1.48
Sham/PlaceboMorphine Equivalent (mg)>75 kg5.5 mg morphineStandard Error 2.17
Secondary

Serum Insulin Level

to determine if electroacupuncture reduced hyperglycemia

Time frame: preoperative and postoperative

Population: female subjects preoperatively and postoperatively

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureSerum Insulin Levelpreoperative257.4 pg/mlStandard Error 92.8
AcupunctureSerum Insulin Levelpostoperative311.2 pg/mlStandard Error 50.59
Sham/PlaceboSerum Insulin Levelpreoperative378.1 pg/mlStandard Error 95.05
Sham/PlaceboSerum Insulin Levelpostoperative325.4 pg/mlStandard Error 84.46
Secondary

TGFB1

TGFB1 is a pleiotropic factor regulating the immune system and healing. First two blood samples drawn under general anesthesia, first prior to surgical incision and EA, the 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia.

Time frame: Preoperatively-intraoperatively-postoperatively

Population: all females; then females by groups age (\<45 years and \>45 years) and weight (\<75kg and \>75kg)

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureTGFB1>75kg postop21.3 pg/mlStandard Error 9.2
AcupunctureTGFB1preoperative7.30 pg/mlStandard Error 3.5
AcupunctureTGFB1intraoperative19.5 pg/mlStandard Error 6.28
AcupunctureTGFB1postoperative35.17 pg/mlStandard Error 8.8
AcupunctureTGFB1<45 yrs post op16.76 pg/mlStandard Error 11.37
AcupunctureTGFB1>45 yrs postop46.2 pg/mlStandard Error 9.9
AcupunctureTGFB1<75 kg postop56.76 pg/mlStandard Error 13.51
Sham/PlaceboTGFB1>75kg postop12.11 pg/mlStandard Error 2.73
Sham/PlaceboTGFB1<45 yrs post op4.89 pg/mlStandard Error 0.48
Sham/PlaceboTGFB1preoperative3.26 pg/mlStandard Error 1.53
Sham/PlaceboTGFB1<75 kg postop13.96 pg/mlStandard Error 5.39
Sham/PlaceboTGFB1intraoperative9.4 pg/mlStandard Error 3.5
Sham/PlaceboTGFB1>45 yrs postop15.2 pg/mlStandard Error 2.8
Sham/PlaceboTGFB1postoperative12.9 pg/mlStandard Error 2.65
Secondary

Tumor Necrosis Factor (TNF)

First two blood samples were collected during general anesthesia, first prior to surgical incision and Electro-acupuncture (EA), 2nd 60 minutes after incision and EA, third after arrival in PACU but before administration of analgesia. TNF is a critical pyrogen produced during acute phase of a reaction to trauma.

Time frame: preoperatively-intraoperatively-postoperatively

Population: female subjects

ArmMeasureGroupValue (MEAN)Dispersion
AcupunctureTumor Necrosis Factor (TNF)intraoperative2.09 pg/mlStandard Error 0.62
AcupunctureTumor Necrosis Factor (TNF)postoperative1.98 pg/mlStandard Error 1
AcupunctureTumor Necrosis Factor (TNF)preoperatively1.88 pg/mlStandard Error 0.67
Sham/PlaceboTumor Necrosis Factor (TNF)preoperatively2.14 pg/mlStandard Error 0.63
Sham/PlaceboTumor Necrosis Factor (TNF)intraoperative2.25 pg/mlStandard Error 0.74
Sham/PlaceboTumor Necrosis Factor (TNF)postoperative1.9 pg/mlStandard Error 0.7

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026